DUMAC Inc’s Burning Rock Biotech BNR Stock Holding History

DUMAC Inc’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,072	Closed	-$248K	–	32
2020 Q4	$248K	Buy	+1,072	New	+$288K	0.19%	32

Other funds holding BNR

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DUMAC Inc's BNR Position: Q1 2021 in Review

DUMAC Inc sold out of Burning Rock Biotech (BNR) in Q1 2021, closing a stake of 1,072 shares — an estimated $248K sold.

DUMAC Inc first reported a position in BNR in Q4 2020 and held it in 1 quarter. The position peaked at $248K in Q4 2020. 54 funds tracked by Wall St. Rank hold BNR as of Q1 2021.

DUMAC Inc reported no remaining Burning Rock Biotech position as of Q1 2021 after selling out during the quarter.
DUMAC Inc sold 1,072 Burning Rock Biotech shares in Q1 2021, an estimated $248K.
DUMAC Inc first reported a position in Burning Rock Biotech in Q4 2020 and held it in 1 quarter.
DUMAC Inc's Burning Rock Biotech position peaked at $248K in Q4 2020.
54 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2021.

Based on DUMAC Inc's 13F filing for Q1 2021, filed 17 May 2021.